Search results - 5 results

Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.

estimate incidence, describe clinical presentation and investigate factors associated with severe outcomes using multivariable analysis. RESULTS: Up to December 31, 2020, 26 countries reported information on ...

Annual Report Belgian Cystic Fibrosis Registry 2018

Accession Number: D/2020/14.440/40 Keywords: annual report Cystic Fibrosis epidemiology mucoviscidose Abstract:   SUMMARY     This report presents the data collected in 2018. It is our hope that the analysis ...

Annual Report Belgian Cystic Fibrosis Registry 2017

Accession Number: D/2019/14.440/16 Keywords: annual report Cystic Fibrosis epidemiology mucoviscidose Abstract: This report presents the data collected in 2017. It is our hope that the analysis of the ...

Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis.

American registry analysis in cystic fibrosis (CF) children showed less lung function decline after starting inhaled corticosteroid (ICS) use. We therefore examined the influence of ICS treatment on lung ...

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.

1555 people with CF, 1452 were included in the analysis. One third were aged <18 years, and 9.4% were solid-organ transplant recipients. 74.5% were symptomatic and 22% were admitted to hospital. In ...

QR code

QR code for this page URL